Previous 10 | Next 10 |
home / stock / ardx / ardx articles
Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected ...
WALTHAM, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, de...
WALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, ...
WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, d...
Ardelyx, Inc. (NASDAQ:ARDX) shares are moving Friday after the company reported its fourth-quarter financial results after the bell Thursday. Here&...
Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter...
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 25 points on Friday. Shares of Ardelyx, Inc. (NASDAQ: AR...
Ardelyx, Inc. (NASDAQ:ARDX) reported its fourth-quarter financial results after the bell Thursday. Here's a look at the details. The Details: ...
WALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, d...
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...